Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
The Laryngoscope|January 12, 2021
One Hundred Cases of Localized Laryngeal Amyloidosis - Evidence for Future ManagementGeorgina Harris, Helen Lachmann, Philip Hawkins, et al.
CEN Case Reports|May 17, 2017
Renal cell carcinoma presenting as AA amyloidosis: a case report and review of the literatureAdarsh Babu, Helen Lachmann, Tom Pickett, et al.
Arthritis and Rheumatism|October 18, 2002
Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximabOri Elkayam, Philip N Hawkins, Helen Lachmann, et al.
The Lancet. Rheumatology|September 7, 2025
VEXAS syndrome and immune-mediated rheumatic diseases: overlaps in clinical features and mechanismsArvind Kaul, Adam Al-Hakim, Helen Lachmann, et al.
Case Reports in Pediatrics|September 19, 2018
Tocilizumab for the Treatment of Mevalonate Kinase DeficiencyNadia K Rafiq, Helen Lachmann, Frodi Joensen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2020
Assessment of the Hemophagocytic Lymphohistiocytosis HScore in Patients With Coronavirus Disease 2019Kristina E N Clark, William D Nevin, Tabitha Mahungu, et al.
Rheumatology Advances in Practice|September 23, 2020
Safety of intravenous anakinra in COVID-19 with evidence of hyperinflammation, a case seriesKristina E N Clark, Oliver Collas, Helen Lachmann, et al.
British Journal of Haematology|August 11, 2018
Real world outcomes of pomalidomide for treatment of relapsed light chain amyloidosisFaye A Sharpley, Richa Manwani, Shameem Mahmood, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 5, 2023
Long-Term Efficacy and Safety of Canakinumab in Patients With Tumor Necrosis Factor Receptor-Associated Periodic Syndrome: Results From a Phase III TrialMarco Gattorno, Laura Obici, Inmaculada Calvo Penadés, et al.
Pageof 7